Iceland· IS-EU/1/25/1931/001-002
Ziihera
A zanidatamab product containing zanidatamab, registered in Iceland by Jazz Pharmaceuticals Ireland Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Zanidatamab is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FD07 (zanidatamab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Zanidatamab · ATC L01FD07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Zanidatamab
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Iceland (IS)
- ATC code
- L01FD07
- ATC class
- Zanidatamab
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zanidatamab in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZIIHERAJazz Pharmaceuticals Ireland Ltd, Dublin
- FinlandZiiheraJazz Pharmaceuticals Ireland Limited
- BelgiumZiihera 300 mgJazz Pharmaceuticals Ireland
- IrelandZiihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Ireland Limited
- PolandZiiheraJazz Pharmaceuticals Ireland Ltd
- SwedenZiihera 300 mg Pulver till koncentrat till infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
- United KingdomZiihera 300mg powder for concentrate for solution for infusion vialsJazz Pharmaceuticals UK Ltd
- United StatesZIIHERAJazz Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ziihera
- Norway · Ziihera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b762cf75-4aca-470b-8d22-65a57bd6b6a0 GET /v1/drugs/b762cf75-4aca-470b-8d22-65a57bd6b6a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stofn fyrir innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01FD07",
"marketed": false,
"strength": "300 mg",
"ma_number": "EU/1/25/1931/001-002",
"substance": "Zanidatamab",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45835"
}See everything about zanidatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.